AQIENTRA · Healthcare, connected.

Document: Terms and Conditions · Version 1.0 · Draft publication date: 5 November 2026

Terms and Conditions

Publication control: This is the initial platform draft. Before public launch, AQIENTRA's legal operating entity, registered address, support contact, governing-law review and any sector-specific contractual terms must be completed and approved by qualified Nigerian counsel.

These Terms and Conditions (“Terms”) govern access to and use of the AQIENTRA website, applications, digital services, marketplaces, professional workspaces and related features (together, the “Platform”). By creating an account, accessing or using the Platform, you agree to these Terms. If you do not agree, do not create an account or use the Platform.

1. About AQIENTRA and key definitions

“AQIENTRA”, “we”, “us” or “our” means the operator of the Platform. The operator's full legal name and registered contact details must be displayed in the final published version. “User” means an individual who accesses the Platform. “Organisation” means a separately registered business, facility, practice, institution or other legal or operating entity using a professional workspace. “Content” includes information, documents, records, images, listings and other material submitted to the Platform.

AQIENTRA is a technology platform that provides digital tools and connections. It is not, merely by providing the Platform, a pharmacy, hospital, diagnostic laboratory, medical practice, manufacturer, wholesaler, courier, insurer or regulator.

2. Eligibility and account registration

3. Individual accounts and independent Organisations

An individual AQIENTRA account is distinct from every Organisation account or workspace. A user may own, administer or be a member of more than one Organisation. Each Organisation remains a separate operating environment with its own records, staff, roles, permissions, branches, settings, subscriptions and activities. Access to one Organisation does not grant access to another. Users must select and operate within the correct Organisation context. No user may access, copy, alter or disclose another Organisation's information without valid authority.

Organisation owners and administrators are responsible for inviting only authorised personnel, assigning appropriate permissions, promptly revoking access when a person leaves or changes role, and ensuring that staff comply with applicable laws and internal procedures.

4. Acceptable use and user responsibilities

You must use the Platform lawfully, honestly and only for its intended purposes. You must not:

5. Healthcare, medicines and professional responsibility

Platform content, medicine information, search results, availability indicators and AI-generated explanations are provided for general informational and operational support. They do not replace professional judgement, a patient-specific assessment, a valid prescription, pharmacist review, diagnostic interpretation, emergency care or advice from an appropriately qualified professional.

Only appropriately authorised professionals may perform regulated professional activities. Users and Organisations remain responsible for licences, registrations, premises approvals, product authorisations, prescriptions, dispensing, patient consent, record keeping, quality systems, pharmacovigilance, controlled medicines and all other statutory obligations applicable to their activities. AQIENTRA does not represent that a listing, provider, product, licence or credential has been independently verified unless the Platform expressly identifies the scope and status of that verification.

6. Organisation workspaces and records

Organisations are responsible for the accuracy and lawful use of information they submit, their configuration of roles and permissions, and the review and approval of operational records. The Platform may provide workflow controls, audit trails, approvals and electronic acknowledgements, but these do not automatically make an Organisation compliant with any law, GMP standard, professional code or regulator requirement. Organisations must validate configured workflows and maintain their own required SOPs, training, oversight, backups and records.

Users must not use a shared account to create or approve records on behalf of another person. Where a feature records a signature or approval, the person using it is responsible for confirming that they have authority and that the action accurately represents their decision.

7. AQI AI and automated assistance

AQI AI may help explain information, search authorised records, summarise content, prepare drafts and suggest operational next steps. AI outputs may be incomplete, inaccurate, outdated or unsuitable for a particular case. You must independently verify material outputs against current, authoritative sources and applicable SOPs.

AQI AI does not independently diagnose, prescribe, dispense, approve or release regulated products, authorise controlled-drug transactions, sign GxP records, make final clinical decisions or replace a responsible professional. Where the Platform restricts an AI action by role or permission, those restrictions apply. Human users remain accountable for decisions and actions they approve or carry out.

8. Listings, enquiries, orders and third-party services

Product, pharmacy, provider, facility and service listings may be supplied by independent third parties. Unless expressly stated otherwise, the listing party is responsible for the accuracy of its information, stock, prices, eligibility, licences and fulfilment. Availability, price, delivery estimates and other commercial details may change and should be confirmed with the relevant provider before reliance or payment.

AQIENTRA does not guarantee that a provider will accept an enquiry, fulfil an order, deliver a product, provide a service or meet a stated timeframe. Any transaction terms, payment obligations, refunds, delivery responsibilities and warranties between users and providers must be clearly presented before the transaction is completed.

9. Fees, subscriptions and payments

Some Platform features may require a paid subscription, service fee or other disclosed charge. Applicable prices, billing intervals, taxes, renewal dates, usage limits, cancellation and refund conditions must be shown before purchase. Unless the checkout expressly states otherwise, subscriptions are not activated merely by creating an account. Organisations are responsible for keeping payment and billing details accurate and for paying charges properly due.

10. Intellectual property and user content

AQIENTRA and its licensors retain rights in the Platform, software, design, branding and materials owned by them. You retain ownership of Content you lawfully submit. You grant AQIENTRA a limited, non-exclusive licence to host, store, process, transmit and display that Content only as reasonably necessary to provide, secure, support and improve the services you use, subject to the Privacy Policy and any applicable data-processing agreement. This licence ends when the Content is deleted or the relevant service ends, except where retention is required by law, security, dispute resolution or legitimate record-keeping obligations.

11. Privacy, confidentiality and security

Our Privacy Policy explains how personal data is handled. Users must protect credentials, use appropriate devices and networks, report suspected compromise promptly and avoid entering unnecessary personal or patient information. Organisations must ensure they have a lawful basis and appropriate notices, permissions and safeguards before placing personal or health information on the Platform.

12. Availability, maintenance and changes

We aim to maintain a reliable service but do not guarantee uninterrupted or error-free availability. We may perform maintenance, modify features, suspend integrations or change service functionality for security, operational, legal or product reasons. We will take reasonable steps to communicate material changes where appropriate. Users and Organisations must maintain independent copies of records where required for their legal or operational obligations.

13. Suspension and termination

We may restrict, suspend or terminate access where reasonably necessary to protect users, Organisations, the Platform or the public; respond to suspected unlawful activity; enforce these Terms; comply with law; address security incidents; or resolve non-payment. Where appropriate and lawful, we will notify the affected user and provide a route to challenge or resolve the issue. Termination does not remove obligations that by their nature continue, including confidentiality, payment, record retention and accrued liability.

14. Disclaimers and limitation of liability

To the extent permitted by applicable law, the Platform is provided on an “as available” basis. We do not warrant that every listing, professional credential, clinical statement, AI output, record or third-party service is accurate, complete or suitable for a particular purpose. Nothing in these Terms excludes liability that cannot lawfully be excluded, including liability for fraud or other non-excludable liability. Subject to that restriction, AQIENTRA will not be liable for indirect, incidental, special or consequential loss, loss of profits, loss of data caused by a user's failure to maintain required backups, or acts and omissions of independent third parties.

15. Indemnity

To the extent permitted by law, you are responsible for losses, claims and reasonable costs arising from your unlawful use of the Platform, breach of these Terms, infringement of third-party rights or misuse of another person's or Organisation's data, except to the extent caused by AQIENTRA's own breach or negligence.

16. Governing law and disputes

These Terms are intended to be governed by the laws of the Federal Republic of Nigeria, subject to confirmation by qualified counsel and any mandatory law applicable to a user or transaction. The parties should first attempt to resolve disputes through good-faith discussions. Nothing in this section prevents a party from seeking urgent relief or exercising a statutory right before a competent authority or court.

17. Changes to these Terms

We may update these Terms to reflect legal, security, operational or product changes. The current version and effective date will be published on the Platform. Where a change materially affects users or requires renewed acceptance, AQIENTRA may ask users to review and accept the new version before continuing to use affected services. We will preserve the version and timestamp of each recorded acceptance.

18. Contact and operator details

Questions, complaints or notices about these Terms should be submitted through AQIENTRA's designated support or contact channel. Before public release, the final document must identify the operator's full legal name, registered address and official contact channel.

Return to AQIENTRA registration →